Risks and Consequences of Outdated or Unapproved Content in Pharma and Consumer Healthcare


Pharmaceutical and consumer healthcare businesses must maintain strict regulatory compliance in all aspects of their operations, including their online presence. The content that is published on the website or social media accounts of these companies can have a significant impact on their reputation, as well as their ability to comply with regulations. Outdated or unapproved content can be a major risk, so it's essential to regularly scan the web portfolio to identify and mitigate these risks. In this white paper, we'll explore the importance of maintaining up-to-date and approved content on pharmaceutical and consumer healthcare websites and social accounts, and introduce our tool Revizor which can help scan web portfolio and identify those outdated or unapproved assets.

 

The Importance of Up-to-Date and Approved Content

In the pharmaceutical and consumer healthcare industry, the consequences of outdated or unapproved content can be severe. Not only can this lead to regulatory non-compliance, but it can also negatively impact the company's reputation, as well as patient safety. Outdated or inaccurate information can mislead patients and healthcare professionals, potentially resulting in negative health outcomes. Additionally, unapproved content can violate regulatory guidelines, leading to significant fines and damage to the company's reputation.

 

Risks Associated with Outdated or Unapproved Content

Outdated or unapproved content on a website or social media account can pose a number of risks, including:

  1. Regulatory Non-Compliance: Outdated or unapproved content can violate regulatory guidelines, leading to fines, regulatory actions, and damage to the company's reputation.

  2. Patient Safety: Outdated or inaccurate information can mislead patients and healthcare professionals, potentially resulting in negative health outcomes.

  3. Damage to Reputation: Unapproved or outdated content can damage the company's reputation and erode trust with patients, healthcare professionals, and regulatory agencies.

 

Revizor - The Solution to Identify Outdated and Unapproved Content

Our tool, Revizor, is a content scanning and management platform that allows pharmaceutical and consumer healthcare companies to identify outdated or unapproved content on their website and social media accounts. Revizor scans all web portfolio for content that is outdated or unapproved, including images, text, and multimedia, and provides a detailed report of the issues that need to be addressed.

Revizor offers the following features:

  1. Automated Scanning: Revizor scans all web portfolio for outdated or unapproved content on a regular basis, saving time and reducing the risk of human error.

  2. Detailed Reports: Revizor provides detailed reports of outdated or unapproved content, making it easy for companies to identify and address issues.

  3. Customizable Alerts: Revizor can be configured to send alerts when new content is added or when content is due for review or update.

  4. Integration with Existing Systems: Revizor integrates with existing content management systems, making it easy to manage content across all web portfolio.

 

In the pharmaceutical and consumer healthcare industry, it's essential to maintain up-to-date and approved content on websites and social media accounts. Outdated or unapproved content can pose significant risks, including regulatory non-compliance, patient safety concerns, and damage to the company's reputation. Our tool, Revizor, offers a comprehensive solution for identifying outdated or unapproved content on all web portfolio, providing detailed reports and alerts to mitigate these risks. By using Revizor, companies can ensure that they are compliant with regulations, maintain patient safety, and protect their reputation.

For more information about how Revizor can support your business monitor its digital assets – email info@uptitude.co.uk

 
Next
Next

Uptitude Investigates Social Media and Brand Confidence